This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is NOT a disadvantage of implementing a multiple baseline design? A. ... (Read 126 times)

tsand2

  • Hero Member
  • *****
  • Posts: 520
Which of the following is NOT a disadvantage of implementing a multiple baseline design?
 
  A. Possibility of covariance of dependent variables
   B. The design is simply conceptualized
   C. There is typically only one intervention phase with each dependent variable
  D. Reducing the opportunities to study the functional relationship with each dependent variable

Question 2

What are the advantages of a multiple baseline design?
 
  A. Withdrawal of treatment is not required
   B. Sequential implementation of the independent variable parallels the practice of teachers
   C. Generalization of behavior change is monitored within the design
   D. All of the above



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

angrybirds13579

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

B

Answer to Question 2

D




tsand2

  • Member
  • Posts: 520
Reply 2 on: Jun 20, 2018
YES! Correct, THANKS for helping me on my review


nanny

  • Member
  • Posts: 313
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Looking at the sun may not only cause headache and distort your vision temporarily, but it can also cause permanent eye damage. Any exposure to sunlight adds to the cumulative effects of ultraviolet (UV) radiation on your eyes. UV exposure has been linked to eye disorders such as macular degeneration, solar retinitis, and corneal dystrophies.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library